Article from August 16, 2018
Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance
FRANKFURT (Reuters) - Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.
https://www.reuters.com/article/us-pfizer-biontech-alliance-idUSKBN1L10F5